Gene therapy and regenerative medicine
3 European H2020 organizations list this as part of their work — 2 as their primary capability.
Most active in this area
- UNIVERSITY COLLEGE LONDON
Major London university with 660+ H2020 projects spanning biomedical research, AI, neuroscience, and materials — among Europe's most funded and connected research institutions.
“Strong early-period focus on gene therapy, tissue engineering, regenerative medicine, and cell therapy, with projects like EUROLEISH-NET and BonePain in related biomedical training networks.”
PrimaryUK662 projects - KING'S COLLEGE LONDON
Major London research university strong in biomedical science, neuroscience, AI-driven health analytics, and digital humanities across 255 H2020 projects.
“Gene therapy appears four times in recent keywords alongside tissue engineering and regenerative medicine from the earlier period, signalling a shift from basic cell biology toward therapeutic applications.”
UK255 projects - VRIJE UNIVERSITEIT BRUSSEL
Brussels-based research university combining AI, gene therapy, and robotics with strong ethics and EU policy expertise across 200 H2020 projects.
“Coordinator of BetaCellTherapy (EUR 3.4M) and MYOCURE on gene therapy for muscle disorders, plus participation in EHVA, EuroStemCell, and SCAFFY on stem cell and adipose tissue research.”
PrimaryBE200 projects